These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 15793804)

  • 1. Evaluation of indomethacin percutaneous absorption from nanostructured lipid carriers (NLC): in vitro and in vivo studies.
    Ricci M; Puglia C; Bonina F; Di Giovanni C; Giovagnoli S; Rossi C
    J Pharm Sci; 2005 May; 94(5):1149-59. PubMed ID: 15793804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of in-vivo topical anti-inflammatory activity of indometacin from liposomal vesicles.
    Puglia C; Trombetta D; Venuti V; Saija A; Bonina F
    J Pharm Pharmacol; 2004 Oct; 56(10):1225-32. PubMed ID: 15482636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanostructured lipid carriers (NLC) based topical gel of flurbiprofen: design, characterization and in vivo evaluation.
    Han F; Yin R; Che X; Yuan J; Cui Y; Yin H; Li S
    Int J Pharm; 2012 Dec; 439(1-2):349-57. PubMed ID: 22989987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and characterization of a novel controlled release drug delivery system based on nanostructured lipid carriers gel for meloxicam.
    Khurana S; Jain NK; Bedi PM
    Life Sci; 2013 Nov; 93(21):763-72. PubMed ID: 24113071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cubosome dispersions as delivery systems for percutaneous administration of indomethacin.
    Esposito E; Cortesi R; Drechsler M; Paccamiccio L; Mariani P; Contado C; Stellin E; Menegatti E; Bonina F; Puglia C
    Pharm Res; 2005 Dec; 22(12):2163-73. PubMed ID: 16267633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poly n-butylcyanoacrylate (PNBCA) nanocapsules as a carrier for NSAIDs: in vitro release and in vivo skin penetration.
    Miyazaki S; Takahashi A; Kubo W; Bachynsky J; Löebenberg R
    J Pharm Pharm Sci; 2003; 6(2):238-45. PubMed ID: 12935436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanoemulsions as vehicles for topical administration of glycyrrhetic acid: characterization and in vitro and in vivo evaluation.
    Puglia C; Rizza L; Drechsler M; Bonina F
    Drug Deliv; 2010 Apr; 17(3):123-9. PubMed ID: 20136625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ocular pharmacokinetics profile of different indomethacin topical formulations.
    Bucolo C; Melilli B; Piazza C; Zurria M; Drago F
    J Ocul Pharmacol Ther; 2011 Dec; 27(6):571-6. PubMed ID: 22059858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polycaprolactone Based Nanoparticles Loaded with Indomethacin for Anti-Inflammatory Therapy: From Preparation to Ex Vivo Study.
    Badri W; Miladi K; Robin S; Viennet C; Nazari QA; Agusti G; Fessi H; Elaissari A
    Pharm Res; 2017 Sep; 34(9):1773-1783. PubMed ID: 28527126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of Indomethacin with Nanostructured Lipid Carriers for Effective Anticancer Therapy.
    Thiruchenthooran V; Espina M; Świtalska M; Bonilla-Vidal L; Wietrzyk J; Garcia ML; Souto EB; Sánchez-López E; Gliszczyńska A
    Int J Nanomedicine; 2024; 19():7033-7048. PubMed ID: 39015675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanostructured lipid carriers-based flurbiprofen gel after topical administration: acute skin irritation, pharmacodynamics, and percutaneous absorption mechanism.
    Song A; Su Z; Li S; Han F
    Drug Dev Ind Pharm; 2015; 41(9):1488-92. PubMed ID: 25231972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid nanoparticles for prolonged topical delivery: an in vitro and in vivo investigation.
    Puglia C; Blasi P; Rizza L; Schoubben A; Bonina F; Rossi C; Ricci M
    Int J Pharm; 2008 Jun; 357(1-2):295-304. PubMed ID: 18343059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minoxidil-loaded nanostructured lipid carriers (NLC): characterization and rheological behaviour of topical formulations.
    Silva AC; Santos D; Ferreira DC; Souto EB
    Pharmazie; 2009 Mar; 64(3):177-82. PubMed ID: 19348340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanostructured lipid carriers (NLCs) versus solid lipid nanoparticles (SLNs) for topical delivery of meloxicam.
    Khalil RM; Abd-Elbary A; Kassem MA; Ghorab MM; Basha M
    Pharm Dev Technol; 2014 May; 19(3):304-14. PubMed ID: 23528038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanostructured lipid carriers based nanogel for meloxicam delivery: mechanistic, in-vivo and stability evaluation.
    Khurana S; Jain NK; Bedi PM
    Drug Dev Ind Pharm; 2015; 41(8):1368-75. PubMed ID: 25151872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local delivery of indomethacin to arthritis-bearing rats through polymeric micelles based on amphiphilic polyphosphazenes.
    Zhang JX; Yan MQ; Li XH; Qiu LY; Li XD; Li XJ; Jin Y; Zhu KJ
    Pharm Res; 2007 Oct; 24(10):1944-53. PubMed ID: 17530389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of artemether-loaded nanostructured lipid carrier (NLC) formulation for topical application.
    Nnamani PO; Hansen S; Windbergs M; Lehr CM
    Int J Pharm; 2014 Dec; 477(1-2):208-17. PubMed ID: 25290810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formulation strategies to modulate the topical delivery of anti-inflammatory compounds.
    Puglia C; Rizza L; Offerta A; Gasparri F; Giannini V; Bonina F
    J Cosmet Sci; 2013; 64(5):341-53. PubMed ID: 24139433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elimination of ketoprofen from the stratum corneum after topical administration with ketoprofen formulations in human subjects.
    Takeshi M; Ebihara T; Maekawa K; Yamamoto K; Higo N
    Int J Pharm; 2014 Apr; 465(1-2):197-201. PubMed ID: 24530385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring the use of spray congealing to produce solid dispersions with enhanced indomethacin bioavailability: In vitro characterization and in vivo study.
    Bertoni S; Albertini B; Ferraro L; Beggiato S; Dalpiaz A; Passerini N
    Eur J Pharm Biopharm; 2019 Jun; 139():132-141. PubMed ID: 30910731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.